PharmaVOICE Blog Post

Meaningful Treatment Benefit from the Patient’s Perspective

Posted By: Dan Limbach
December 3, 2018

Instant download of paper

Have you been told by the U.S. Food and Drug Administration (FDA) to include the patient’s perspective about treatment benefit in your drug development program? If so, were you prepared to provide it?

Evidera’s recent paper regarding the patients’ perspective on clinical trial treatment benefits provides insights into why this feedback is so important and how to obtain it.

Key Topics:

  • With the 21st Century Cures Act, there is an increased focus on the patient’s perspective and now, more than ever, regulators are seeking feedback from patients throughout the drug development process
  • Concepts being evaluated from the patient’s perspective should be meaningful and relevant to the patients
  • Qualitative research can be conducted to evaluate a meaningful treatment benefit both before and during clinical trial implementation

Download this white paper for more information on this topic.

Instant download:

About the Blog Poster: Dan Limbach

Comments are closed.